Most recently, it has been discovered that conolidine and the above mentioned derivatives act over the atypical chemokine receptor 3 (ACKR3. Expressed in identical regions as classical opioid receptors, it binds to a big selection of endogenous opioids. Compared with most opioid receptors, this receptor acts like a scavenger https://johnd061tjz6.wikibriefing.com/user